Manassas, VA, July 28, 2020 (GLOBE NEWSWIRE) -- Real-world data on the performance of the ForeseeHome® AMD Monitoring Program, which helps detect the conversion from intermediate dry to wet ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW YORK — Patients with age-related macular ...

Manassas, VA, April 26, 2022 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today the publication of the Analysis of Long-term visual Outcomes of ForeseeHome Remote Telemonitoring (ALOFT) study ...

CHANTILLY, Va.--(BUSINESS WIRE)--Notal Vision, Inc. is pleased to announce that the ForeseeHome AMD Monitoring Program is now available for eligible Medicare patients across the U.S. ForeseeHome is ...

MANATEE -- Dr. Joshua Mali of The Eye Associates is admired by fellow Manatee and Sarasota county retina specialists for the extent he will go for his patients, a co-worker said of him. "He's a ...

Although technology is allowing for earlier detection of eye conditions, lack of reimbursement and insurance coverage remain major barriers to widespread use, explained speakers at the American ...

CHANTILLY, Va.--(BUSINESS WIRE)--Notal Vision, Inc. recently recorded its one-millionth individual test on its ForeseeHome® AMD Monitoring System. The ForeseeHome AMD Monitoring System is the first ...

MANASSAS, Va., Oct. 5, 2017 /PRNewswire/ -- Notal Vision, Inc., a pioneer in home-based ophthalmic disease monitoring, announced the completion of the three millionth home test performed with ...

Please provide your email address to receive an email when new articles are posted on . The ForeseeHome AMD monitoring program is available by prescription for eligible Medicare patients in the U.S.

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older Americans. AMD is a degenerative disease that affects the macula, or the central part of the retina, which ...

ST. LOUIS, June 15 The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2). AREDS2 is ...

Eligible patients enrolled in Medicare across the U.S. now have ...